Nasdaq
$0.9650▼ 0.02%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $43.2MShares out 44.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
22- 5d agoAfter-hours26.10.20 06:084Ownership#●●●
TELA Bio, Inc.
Insider Joseph H. Capper of TELA Bio, Inc. filed a Form 4 on October 19, 2026, reporting a change in beneficial ownership of securities effective as of October 15, 2026. This filing details the specific changes in the insider's equity holdings.…more
$0.9650-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoAfter-hours26.10.20 06:074Ownership
TELA Bio, Inc.
Insider William J. Plovanic of TELA Bio, Inc. filed a Form 4 report regarding changes in beneficial ownership of securities as of October 15, 2026. This filing details the adjustments in the insider's equity holdings.…more
$0.9650-0.02%vs prev closeView filingShare - 10.8After-hours26.10.09 05:058-KKey event
TELA Bio, Inc.
TELA Bio has decided not to proceed with the previously approved reverse stock split as the company regained compliance with the Nasdaq minimum bid price requirement on October 5, 2026. As of September 8, 2026, the company had 45,143,410 shares of common stock outstanding.…more
$0.9650-0.02%vs prev closeView filingShare
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.5Pre-market26.10.05 21:00#●●●#●●●#●●●
TELA Bio Receives FDA 510(k) Clearance for Liora Soft Tissue Scaffold
TELA Bio has received FDA 510(k) clearance for its new Liora monofilament scaffold designed for soft tissue reconstruction. While this expands the company's product portfolio, the impact on future revenue and profitability remains to be seen.…more
$0.9650-0.02%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 8.31Pre-market26.08.31 20:10
●●●●●●●● ●●●●● ●●●●●●
TELA Bio is implementing a restructuring plan to reduce annual operating expenses by $17 million, including a 20% workforce reduction. This initiative aims to streamline operations and extend the company's cash runway through 2028.…more
$0.9650-0.02%vs prev closeShareBenzinga - 8.31Pre-market26.08.31 20:09
●●●●●●●● ●●●●● ●●●●●●
TELA Bio announced that Roberto Cuca, its Chief Operating Officer and Chief Financial Officer, has stepped down from his roles effective immediately. This sudden departure of a key executive may introduce operational uncertainty for the company.…more
$0.9650-0.02%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report